4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0000950170-24-019045
Chief R&D Officer sold 9,014 shares at $0.68 ($6,130)
From the SEC's structured data for this filing
NEKTAR THERAPEUTICS Filed Acc 0000950170-24-019045
Chief R&D Officer sold 9,014 shares at $0.68 ($6,130)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…